5-Aza-2-deoxycytidine alleviates the progression of primary biliary cholangitis by suppressing the FoxP3 methylation and promoting the Treg/Th17 balance-Reference-Cited by-同舟云学术

5-Aza-2-deoxycytidine alleviates the progression of primary biliary cholangitis by suppressing the FoxP3 methylation and promoting the Treg/Th17 balance

Published:2021-07 Issue: Volume:96 Page:107820
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Jiang Ting,Zhang Hong-wei,Wen Yan-ping,Yin Yue-shan,Yang Li-hong,Yang Jing,Lan Tian,Tang Cheng-wei,Yu Jian-kun,Tai Wen-lin,Yang Jin-hui

Funder

National Natural Science Foundation of China

Yunnan Provincial Department of Education

Yunnan Provincial Science and Technology Department

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference43 articles.

1. Primary biliary cholangitis: pathogenesis and therapeutic opportunities;Gulamhusein;Nat. Rev. Gastroenterol. Hepat.,2019

2. The genetics of primary biliary cholangitis;Tanaka;Curr. Opin. Gastroenterol.,2019

3. A validation study of the Ursodeoxycholic Acid Response Score in Japanese patients with primary biliary cholangitis;Yagi;Liver Int.,2020

4. Apotopes and the biliary specificity of primary biliary cirrhosis;Ana;Hepat.,2009

5. Biliary apotopes and anti-mitochondrial antibodies activate innate immune responses in primary biliary cirrhosis;Ana;Hepat.,2010

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypermethylation of the FOXP3 gene regulates Tregs immunodysregulation in chronic idiopathic thrombocytopenic purpura;Allergologia et Immunopathologia;2024-07-01

2. Epigenetic basis of autoimmune disorders in humans;Epigenetics in Human Disease;2024

3. Animal models of primary biliary cholangitis: status and challenges;Cell & Bioscience;2023-11-22

4. Hypermethylation of the ADIRF promoter regulates its expression level and is involved in NNK-induced malignant transformation of lung bronchial epithelial cells;Archives of Toxicology;2023-10-01

5. Mechanism-based target therapy in primary biliary cholangitis: opportunities before liver cirrhosis?;Frontiers in Immunology;2023-05-30